Antisense Therapeutics Ltd. | Balance Sheet
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,334.50
6,829.60
4,800.70
1,902.00
4,299.10
Total Accounts Receivable
1,167.90
744.50
420.30
427.90
331.20
Other Current Assets
140.10
93.50
102.90
195.10
164.20
Total Current Assets
2,642.40
7,667.60
5,324.00
2,525.00
4,794.50
Net Property, Plant & Equipment
13.60
5.40
3.40
14.10
7.70
Total Assets
2,656.00
7,673.00
5,327.40
2,539.10
4,802.10
ST Debt & Current Portion LT Debt
50.00
-
-
-
-
Accounts Payable
116.90
161.80
214.80
165.70
103.80
Other Current Liabilities
402.30
419.60
535.40
520.00
477.10
Total Current Liabilities
569.10
581.40
750.20
685.70
580.90
Total Liabilities
569.10
581.40
750.20
685.70
580.90
Common Equity (Total)
2,086.90
7,091.60
4,577.20
1,853.40
4,221.30
Total Shareholders' Equity
2,086.90
7,091.60
4,577.20
1,853.40
4,221.30
Total Equity
2,086.90
7,091.60
4,577.20
1,853.40
4,221.30
Liabilities & Shareholders' Equity
2,656.00
7,673.00
5,327.40
2,539.10
4,802.10
About Antisense Therapeutics
View Profile
